SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
- Just – Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and ...
Biologics developers are caught in a paradox: demand for therapies is climbing, but the industry faces constant pressure to cut costs and move faster. For upstream process scientists, the challenge is ...
In manufacturing, intensification is an attractive idea. The ability to make more product, for less, using fewer resources, makes economic sense. In practice, however, it is a complex undertaking that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback